Nagai et al. already stated higher HNRNPK protein levels in ER positive breast cancer tissues compared to ER negative tumors which fits our observations of increased HNRNPK mRNA and protein level upon ligand‐activated ERα in OK cells (Nagai et al., 2004). The gene discussed is HNRNPK; the disease is breast cancer.